Your browser doesn't support javascript.
loading
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy.
Yoshida, Chikashi; Kondo, Takeshi; Ito, Tomoki; Kizaki, Masahiro; Yamamoto, Kazuhiko; Miyamoto, Toshihiro; Morita, Yasuyoshi; Eto, Tetsuya; Katsuoka, Yuna; Takezako, Naoki; Uoshima, Nobuhiko; Imada, Kazunori; Ando, Jun; Komeno, Takuya; Mori, Akio; Ishikawa, Yuichi; Satake, Atsushi; Watanabe, Junichi; Kawakami, Yoshiko; Morita, Tetsuo; Taneike, Ikue; Nakayama, Masahiko; Duan, Yinghui; Garbayo Guijarro, Belen; Delgado, Alexander; Llamas, Cynthia; Kiyoi, Hitoshi.
Afiliação
  • Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki-machi, Japan. c.yoshida@mitomedical.org.
  • Kondo T; Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.
  • Ito T; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
  • Kizaki M; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Yamamoto K; Department of Hematology, Okayama City Hospital, Okayama, Japan.
  • Miyamoto T; Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Morita Y; Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University, Osaka, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Katsuoka Y; Department of Hematology, Sendai Medical Center, National Hospital Organization, Sendai, Japan.
  • Takezako N; Department of Hematology, Disaster Medical Center, Tokyo, Japan.
  • Uoshima N; Department of Hematology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
  • Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Komeno T; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki-machi, Japan.
  • Mori A; Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.
  • Ishikawa Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Satake A; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
  • Watanabe J; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Kawakami Y; AbbVie GK, Tokyo, Japan.
  • Morita T; AbbVie GK, Tokyo, Japan.
  • Taneike I; AbbVie GK, Tokyo, Japan.
  • Nakayama M; AbbVie GK, Tokyo, Japan.
  • Duan Y; AbbVie, Inc., North Chicago, IL, USA.
  • Garbayo Guijarro B; AbbVie, Inc., Madrid, Spain.
  • Delgado A; AbbVie, Inc., Singapore, Singapore.
  • Llamas C; AbbVie, Inc., North Chicago, IL, USA.
  • Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Int J Hematol ; 116(1): 89-101, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35394258
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Asia Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Asia Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão